To summarize the current spectrum of endoluminal vacuum therapy (EVT) in the foregut and provide an overview of the literature, highlighting its clinical significance.
Key Findings:
EVT has high success rates (specific rates needed) and low complication rates for treating upper GI defects.
Compared to endoscopic stenting, EVT shows higher closure rates and shorter treatment durations (specific metrics needed).
EVT is limited in the proximal esophagus and gastric lesions due to difficulty in creating a sealed environment.
Interpretation:
EVT is increasingly recognized as a valuable tool in managing upper GI tract defects, with evidence from multiple studies supporting its efficacy and safety.
Patients must remain nil by mouth during treatment, which may not be tolerated by all, affecting quality of life.
Conclusion:
EVT represents a significant advancement in the treatment of upper GI tract defects, offering advantages over traditional methods and warranting further research.
